DiaMedica Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

DiaMedica Therapeutics

06/05/2021 11:19

* DiaMedica Therapeutics Inc  DMAC.OQ  reported a quarterly
adjusted loss of 19 cents​​ per share for the quarter ended
in March. The mean expectation of six analysts for the quarter
was for a loss of 21 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* DiaMedica Therapeutics Inc's reported EPS for the quarter was
a loss of 19 cents​.
* The mean earnings estimate of analysts had fallen by
about 9.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* DiaMedica Therapeutics Inc shares had risen by 3.2% this
quarter and lost 6.9% so far this year.
* The company reported a quarterly loss of $3.62 million.
* Wall Street's median 12-month price target for DiaMedica
Therapeutics Inc is $25.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 10:18 a.m. GMT. ​All
figures in US Dollars.​